Liberia to get experimental Ebola drug to treat two doctors; infected Spanish priest dies in hospital

Liberia will receive enough of an experimental Ebola drug to treat just two infected Liberian doctors, Information Minister Lewis Brown said, after the United States Food and Drug Administration (FDA) approved its export.

Brown said Liberia's Health Ministry had contacted the US manufacturer of ZMapp, Mapp Biopharmaceutical, and asked the FDA to quickly approve its export. The doctors had consented in writing to the treatment, the minister said.

Meanwhile, a spanish priest infected with the Ebola virus, the first European to contract the deadly disease, has died in hospital, a spokeswoman from Madrid health authorities said on Tuesday.

Pajares, 75, was airlifted from Liberia on August 7 after contracting the disease while working for a non-governmental organisation in the African country. He was repatriated with co-worker Juliana Bohi, a nun who has tested negative for the disease.